STE
Price
$245.06
Change
+$0.29 (+0.12%)
Updated
Aug 29 closing price
Capitalization
24.14B
72 days until earnings call
XRAY
Price
$14.30
Change
-$0.02 (-0.14%)
Updated
Aug 29 closing price
Capitalization
2.85B
61 days until earnings call
Interact to see
Advertisement

STE vs XRAY

Header iconSTE vs XRAY Comparison
Open Charts STE vs XRAYBanner chart's image
STERIS
Price$245.06
Change+$0.29 (+0.12%)
Volume$561.73K
Capitalization24.14B
DENTSPLY SIRONA
Price$14.30
Change-$0.02 (-0.14%)
Volume$1.86M
Capitalization2.85B
STE vs XRAY Comparison Chart in %
Loading...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STE vs. XRAY commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STE is a StrongBuy and XRAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (STE: $245.06 vs. XRAY: $14.30)
Brand notoriety: STE and XRAY are both not notable
STE represents the Medical/Nursing Services, while XRAY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: STE: 93% vs. XRAY: 56%
Market capitalization -- STE: $24.14B vs. XRAY: $2.85B
STE [@Medical/Nursing Services] is valued at $24.14B. XRAY’s [@Pharmaceuticals: Other] market capitalization is $2.85B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STE’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • STE’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, STE is a better buy in the long-term than XRAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STE’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).

  • STE’s TA Score: 4 bullish, 6 bearish.
  • XRAY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than STE.

Price Growth

STE (@Medical/Nursing Services) experienced а -2.70% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.47%. For the same industry, the average monthly price growth was +5.74%, and the average quarterly price growth was +15.16%.

Reported Earning Dates

STE is expected to report earnings on Nov 10, 2025.

XRAY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.47% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($24.1B) has a higher market cap than XRAY($2.85B). STE YTD gains are higher at: 19.805 vs. XRAY (-23.110). STE has higher annual earnings (EBITDA): 1.41B vs. XRAY (-689M). XRAY has more cash in the bank: 359M vs. STE (280M). STE has less debt than XRAY: STE (2.07B) vs XRAY (2.49B). STE has higher revenues than XRAY: STE (5.57B) vs XRAY (3.67B).
STEXRAYSTE / XRAY
Capitalization24.1B2.85B845%
EBITDA1.41B-689M-204%
Gain YTD19.805-23.110-86%
P/E Ratio37.47N/A-
Revenue5.57B3.67B152%
Total Cash280M359M78%
Total Debt2.07B2.49B83%
FUNDAMENTALS RATINGS
STE vs XRAY: Fundamental Ratings
STE
XRAY
OUTLOOK RATING
1..100
1752
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
7196
PRICE GROWTH RATING
1..100
3164
P/E GROWTH RATING
1..100
6487
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (5) in the Medical Specialties industry is somewhat better than the same rating for STE (56). This means that XRAY’s stock grew somewhat faster than STE’s over the last 12 months.

STE's Profit vs Risk Rating (43) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

STE's SMR Rating (71) in the Medical Specialties industry is in the same range as XRAY (96). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

STE's Price Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for XRAY (64). This means that STE’s stock grew somewhat faster than XRAY’s over the last 12 months.

STE's P/E Growth Rating (64) in the Medical Specialties industry is in the same range as XRAY (87). This means that STE’s stock grew similarly to XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEXRAY
RSI
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 12 days ago
51%
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
39%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIUTX17.06N/A
N/A
Eaton Vance Dividend Builder I
VAFFX35.51N/A
N/A
Invesco American Franchise R6
GTMIX17.36N/A
N/A
GMO International Opportunistic Val III
GRETX11.51N/A
N/A
Goldman Sachs Real Estate Securities Inv
ARAIX79.03N/A
N/A
Ariel Fund Institutional

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+0.12%
SYK - STE
55%
Loosely correlated
+0.45%
LH - STE
50%
Loosely correlated
+0.98%
DHR - STE
49%
Loosely correlated
+0.26%
MDT - STE
49%
Loosely correlated
+0.92%
WAT - STE
49%
Loosely correlated
+1.39%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.14%
NVST - XRAY
53%
Loosely correlated
-0.33%
QDEL - XRAY
50%
Loosely correlated
+2.46%
KIDS - XRAY
48%
Loosely correlated
-0.37%
STE - XRAY
46%
Loosely correlated
+0.12%
AZTA - XRAY
46%
Loosely correlated
+2.07%
More